4//SEC Filing
Hunter Robyn 4
Accession 0001144204-18-062675
CIK 0001429260other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 5:26 PM ET
Size
5.9 KB
Accession
0001144204-18-062675
Insider Transaction Report
Form 4
Hunter Robyn
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-11-23$1.29/sh−20,370$26,277→ 239,759 total
Footnotes (3)
- [F1]In connection with the vesting of 62,500 shares on November 20, 2018, a total of 20,370 of such shares were sold by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
- [F2]Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on November 23, 2018, was $1.28 to $1.34. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Of the 239,759 shares, 187,500 shares are restricted stock units.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001713932
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 5:26 PM ET
- Size
- 5.9 KB